Loading...
Trametinib response in heavily pretreated high-grade ovarian cancer: One step towards precision medicine
Traditional treatment failure in recurrent ovarian cancer remains a challenge for clinicians. Tumor genetic testing is a promising tool which has been proved able to identify sensitivity profiles in patients affected by cancers. This may be helpful in choosing targeted systemic treatments, aiming to...
Saved in:
| Published in: | Gynecol Oncol Rep |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Elsevier
2020
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7042411/ https://ncbi.nlm.nih.gov/pubmed/32128357 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.gore.2020.100547 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|